2022. Introducing innovative cellular therapies into the clinic: a 2-year retrospective experience of a chimeric antigen receptor T-cell programme at a single centre in Switzerland. Swiss Medical Weekly. 152, 2526 (Jun. 2022), w30186. DOI:https://doi.org/10.4414/SMW.2022.w30186.